• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us

Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

Future of Food - Plant Based Meat or Lab Grown Meat

The Future of Food: What to Expect from Australia’s Latest Shortage

By Ryan Clarkson-Ledward, Thursday, 06 August 2020

It’s all part of a much bigger trend in food. One that will likely see most of us eating plant-based or lab-grown proteins. Some of which may be designed to mimic meat, and some of which won’t. Either way, expect the future of food to dish up a few surprises…

ASX ATH Share Price - Alterity Therapeutics Ltd

Alterity Therapeutics Shares Soar on Confirmation of Breakthrough

By Ryan Clarkson-Ledward, Tuesday, 04 August 2020

At the end of the day, society still faces a lot of health risks. Including a myriad of disease and ailments that are just as deadly as COVID-19, albeit far less pronounced. At least, for now. That’s where Alterity Therapeutics Ltd [ASX:ATH] comes into the fold…

ASX MSB - Mesoblast Share Price

Mesoblast Share Price Up, Nears Major Milestone (ASX:MSB)

By Carl Wittkopp, Tuesday, 04 August 2020

The share price of Mesoblast Ltd [ASX:MSB] is up on the back of news the company is due to complete their first interim analysis in early September. This is for their Phase 3 trial of their lead product for COVID-19 Acute Respiratory Distress Syndrome (ARDS)…

Stock Market Direction - Which way will the stock market go?

The Real Enemy for Investors: Which direction will the stock market go?

By Ryan Dinse, Tuesday, 28 July 2020

You’ll hear persuasive arguments on both sides telling you what will happen next over the coming months. And you do really have to be ready for anything. Now, to my mind, that doesn’t mean sitting in cash. That’s a false comfort, especially if markets continue to rally…

ASX MX1 Share Price - ASX Micro-X Shares

Micro-X Share Price Higher Thanks to ‘Rover’ Approval (ASX:MX1)

By Lachlann Tierney, Monday, 20 July 2020

Australian x-ray products manufacturer Micro-X Ltd [ASX:MX1] has had its share price open higher today thanks to record time FDA approval for its ‘Rover’ device. MX1 designs and develops lightweight x-ray products for global healthcare and security markets…

ASX RSH Share Price - Respiri Shares

Respiri Share Price Up 22% on the Back of a New Deal

By Ryan Clarkson-Ledward, Friday, 17 July 2020

For those with existing respiratory illnesses, like asthma, it has been an even more challenging time. COVID-19 being a far more deadly threat. Which is precisely why companies like Respiri Ltd [ASX:RSH] and their technology are so important….

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Go to Next Page »

Primary Sidebar

Technology Categories

  • Technology
  • Artificial Intelligence
  • Bitcoin
  • Cryptocurrency
  • Energy
  • Financial Technology
  • Bio Technology

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988